CRF Health introduces TrialSlate™ 1.0.2 Software

December 7, 2009 Naor Chazan

Lansdale, PA – December 7, 2009: CRF Health, a leading provider of electronic Patient Reported Outcomes (ePRO) and wireless data collection solutions for the life sciences industry, has announced the global release of its TrialSlate™1.0.2 Software, an updated version of its TrialSlate application launched earlier this year.

The original TrialSlate application was specifically designed to support larger screen tablet PCs. The Version 1.0.2 expands the TrialSlate’s application’s capabilities with new features including support for the Gigabyte™ T1028X, support for complex script languages, landline support with an external modem, and a new antivirus application. “Tablet PCs are becoming increasingly popular for ePRO data collection,” notes John Jordan, chief operating officer at CRF Health. “Their larger screens allow them to display many commonly used data instruments in a manner almost identical to their paper-based counterparts, often reducing the need for additional validation. This makes them ideal choices for certain clinical trials.”

The emergence of new and relatively inexpensive netbooks such as the Gigabyte T1028X was a key factor in the development of TrialSlate 1.0.2., said Jordan.

“Budgetary considerations have made these devices more appealing to some sponsors and investigators,” he notes. “The TrialSlate software was originally validated for the Motion LE1700. Now that it also supports the Gigabyte T1028X, sponsors will have two device options to choose from.”

Pekka Keskiivari, chief technical officer at CRF Health, notes that the newly released TrialSlate solution “means more flexibility in supporting different kinds of studies and site environments. TrialSlate can now be used for site-based ePRO in any language, including Middle-Eastern and Indian complex scripts. Study teams can rely on one ePRO solution to cover all countries in global studies.”

“At CRF Health, we are committed to delivering the very best in technology and product support to our clients,” said Jordan. “We’ve received very positive feedback from clients and investigative sites using our TrialSlate solution, and will continue working to meet the needs of the ever-evolving clinical trial industry.”

TrialSlate™ 1.0.2/Product Highlights

  • Support for complex script languages
  • Landline support with an external USB 56K modem
  • Validated for both the Motion LE1700 and Gigabyte T1028
  • New operating system image versions for both the Motion LE1700 and Gigabyte T1028
  • New protocol commands for improved handling of power management

#

About CRF Health

CRF Health is a global leader in ePRO (electronic Patient Reported Outcomes) solutions for the life sciences industry. Through innovative technology, a thorough understanding of drug development and mobile computing, CRF Health is driving the change to higher quality outcomes and more efficient paper-free clinical trials.

CRF Health’s ePRO technology has been used in more than 60 countries, on six continents and 68 regional languages, including ten regional Indian dialects. CRF Health consistently demonstrates the industry’s highest patient compliance rates while delivering unrivalled data accuracy and unmatched patient and site acceptance.

Since its founding in 2000, CRF Health continues to provide true global ePRO delivery and service. Headquartered in the US, CRF Health operates its R&D center of excellence in Helsinki, Finland and has offices around the world.

TrialSlate™ and other CRF product references are either a trademark or service mark of CRF Inc. d/b/a CRF Health. All other trademarks and/or service marks of any other company are the property of their respective owners.

For more information, please visit www.crfhealth.com.

Media Contact
Heather Bilinski, Marketing Manager
CRF Health
4000 Chemical Road, Suite 400
Plymouth Meeting, PA 19462
Phone: +1 267.498.2349 | Fax: +1 215.565.0001
heather.bilinski@crfhealth.com

Previous
CRF Health reports record growth and earnings

Next
CRF Health Announces Company Promotions

Now Available: 5 Best Practices for Using Connected Devices in Clinical Trials

Watch Now